| scholarly article | Q13442814 |
| P50 | author | Jason S. Lewis | Q41485356 |
| Philip J Blower | Q60617592 | ||
| P2093 | author name string | Michael J Welch | |
| Jason L J Dearling | |||
| Gregory E D Mullen | |||
| P433 | issue | 3 | |
| P921 | main subject | copper | Q753 |
| hypoxia | Q105688 | ||
| P304 | page(s) | 249-259 | |
| P577 | publication date | 2001-09-08 | |
| P1433 | published in | Journal of Biological Inorganic Chemistry | Q3186899 |
| P1476 | title | Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships | |
| P478 | volume | 7 |
| Q57814855 | A Modular Ionophore Platform for Liver-Directed Copper Supplementation in Cells and Animals |
| Q90299911 | A brief overview of metal complexes as nuclear imaging agents |
| Q38900380 | A dual radiolabelling approach for tracking metal complexes: investigating the speciation of copper bis(thiosemicarbazonates) in vitro and in vivo |
| Q39079811 | A highly sensitive long-wavelength fluorescence probe for nitroreductase and hypoxia: selective detection and quantification |
| Q38269216 | A nuclear chocolate box: the periodic table of nuclear medicine. |
| Q34919551 | Alzheimer's disease & metals: therapeutic opportunities |
| Q42232549 | Antimicrobial effects of copper(II) bis(thiosemicarbazonato) complexes provide new insight into their biochemical mode of action |
| Q46552901 | Applications of "Hot" and "Cold" Bis(thiosemicarbazonato) Metal Complexes in Multimodal Imaging |
| Q35565683 | Assessing tumor hypoxia by positron emission tomography with Cu-ATSM |
| Q53073038 | Cardiac hypoxia imaging: second-generation analogues of 64Cu-ATSM. |
| Q39646883 | Cell cycle arrest in cultured neuroblastoma cells exposed to a bis(thiosemicarbazonato) metal complex. |
| Q37506093 | Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection |
| Q33870879 | Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease |
| Q26748245 | Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations |
| Q39796655 | Copper and zinc bis(thiosemicarbazonato) complexes with a fluorescent tag: synthesis, radiolabelling with copper-64, cell uptake and fluorescence studies |
| Q37970312 | Copper complexes as therapeutic agents |
| Q37853427 | Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals |
| Q48544553 | Copper complexes with dissymmetrically substituted bis(thiosemicarbazone) ligands as a basis for PET radiopharmaceuticals: control of redox potential and lipophilicity. |
| Q28272734 | Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD |
| Q44484795 | Copper modulates the large dense core vesicle secretory pathway in PC12 cells. |
| Q36075898 | Copper(II)-Bis(Thiosemicarbazonato) Complexes as Antibacterial Agents: Insights into Their Mode of Action and Potential as Therapeutics. |
| Q37126530 | Copper-64 Radiopharmaceuticals for Oncologic Imaging |
| Q37478003 | Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research |
| Q52632779 | Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells. |
| Q42621214 | Crystal structure of [butane-2,3-dione bis-(4-methyl-thio-semicarbazonato)-κ(4) S,N (1),N (1'),S'](pyridine-κN)zinc(II). |
| Q60327459 | Design considerations towards simultaneously radiolabeled and fluorescent imaging probes incorporating metallic species |
| Q40356329 | Distribution of sigma receptors in EMT-6 cells: preliminary biological evaluation of PB167 and potential for in-vivo PET. |
| Q92948694 | Does the ATSM-Cu(II) Biomarker Integrate into the Human Cellular Copper Cycle? |
| Q39431439 | Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: Synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes |
| Q37414432 | Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines. |
| Q39540051 | Fluorescent gallium and indium bis(thiosemicarbazonates) and their radiolabelled analogues: synthesis, structures and cellular confocal fluorescence imaging investigations. |
| Q33838170 | Fluorescent/phosphorescent dual-emissive conjugated polymer dots for hypoxia bioimaging |
| Q26784016 | Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging |
| Q38037430 | Hypoxia Imaging Agents Labeled with Positron Emitters |
| Q36659868 | Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy |
| Q39636702 | Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM. |
| Q35676947 | Imaging oxygenation of human tumours |
| Q34322676 | In Vitro and in Vivo Anticancer Activity of Copper Bis(thiosemicarbazone) Complexes |
| Q35504360 | In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia |
| Q51677717 | In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM |
| Q31082029 | Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes |
| Q41679298 | Inhibition of respiratory complex I by copper(ii)-bis(thiosemicarbazonato) complexes. |
| Q33480211 | Macrocyclic diamide ligand systems: potential chelators for 64Cu- and 68Ga-based positron emission tomography imaging agents |
| Q57099964 | Menkes disease: Oral administration of glyoxal-bis(N(4)-methylthiosemicarbazonato)-copper(II) rescues the macular mouse |
| Q37957126 | Metal attenuating therapies in neurodegenerative disease |
| Q37373364 | Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease |
| Q36944378 | Modification of intracellular glutathione status does not change the cardiac trapping of (64)Cu(ATSM) |
| Q38014896 | Modulating metals as a therapeutic strategy for Alzheimer's disease |
| Q37378239 | Molecular imaging of hypoxia with radiolabelled agents |
| Q38448424 | Molecular imaging with copper-64 in the drug discovery and development arena |
| Q47124032 | Multiple Administrations of 64Cu-ATSM as a Novel Therapeutic Option for Glioblastoma: a Translational Study Using Mice with Xenografts. |
| Q35545523 | Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia. |
| Q58147397 | Opportunities and Challenges for Metal Chemistry in Molecular Imaging |
| Q52661554 | Oxygen Sensing, Hypoxia Tracing and in Vivo Imaging with Functional Metalloprobes for the Early Detection of Non-communicable Diseases. |
| Q52668221 | PET Imaging of Cardiac Hypoxia: Hitting Hypoxia Where It Hurts. |
| Q51692938 | PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease. |
| Q37904019 | PET imaging of cardiac hypoxia: opportunities and challenges. |
| Q36335266 | Pharmacokinetic Analysis of (64)Cu-ATSM Dynamic PET in Human Xenograft Tumors in Mice |
| Q37295067 | Pharmacotherapeutic targets in Alzheimer's disease |
| Q30575110 | Practical Dynamic Contrast Enhanced MRI in Small Animal Models of Cancer: Data Acquisition, Data Analysis, and Interpretation |
| Q46911811 | Probing the mechanism of hypoxia selectivity of copper bis(thiosemicarbazonato) complexes: DFT calculation of redox potentials and absolute acidities in solution |
| Q36934661 | QSAR studies of copper azamacrocycles and thiosemicarbazones: MM3 parameter development and prediction of biological properties. |
| Q38959092 | Quantitative measurement of redox potential in hypoxic cells using SERS nanosensors |
| Q35650691 | RETRACTED: PET imaging of tumour hypoxia |
| Q39774180 | Radiobiological effects of hypoxia-dependent uptake of 64Cu-ATSM: enhanced DNA damage and cytotoxicity in hypoxic cells |
| Q38196380 | Radiocopper for the imaging of copper metabolism |
| Q34235986 | Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET |
| Q39243860 | Reversible Off–On Fluorescence Probe for Hypoxia and Imaging of Hypoxia–Normoxia Cycles in Live Cells |
| Q90455305 | Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation |
| Q46845387 | Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide |
| Q48004140 | Studies of copper trafficking in a mouse model of Alzheimer's disease by positron emission tomography: comparison of 64Cu acetate and 64CuGTSM. |
| Q39472109 | Subcellular localization of a fluorescent derivative of CuII(atsm) offers insight into the neuroprotective action of CuII(atsm). |
| Q53273663 | Syntheses and structures of discrete copper(II) and cadmium(II) supramolecular complexes based on 1,4-diacylthiosemicarbazone ligands |
| Q47141019 | Synthesis and Cytotoxic Evaluation of Steroidal Copper (Cu (II)) Complexes |
| Q51655778 | Synthesis of sulfonamide conjugates of Cu(II), Ga(III), In(III), Re(V) and Zn(II) complexes: carbonic anhydrase inhibition studies and cellular imaging investigations. |
| Q50848539 | Synthesis, characterisation and evaluation of a novel copper-64 complex with selective uptake in EMT-6 cells under hypoxic conditions |
| Q40043661 | Synthesis, in vitro and in vivo characterization of (64)Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands. |
| Q39337383 | Synthesis, radiolabeling and biological evaluation of propylene amine oxime complexes containing nitrotriazoles as hypoxia markers. |
| Q53227485 | Towards new horizons in brain PET. |
| Q34119201 | Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals |
Search more.